thienopyridines

You have accessRestricted access
Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy)Clinical Perspective
Ada C. Stefanescu Schmidt, Dean J. Kereiakes, Donald E. Cutlip, Robert W. Yeh, Ralph B. D’Agostino, Joseph M. Massaro, Wen-Hua Hsieh and Laura Mauri On behalf of the DAPT Investigators

Circulation. 2017;135:1720-1732, originally published February 22, 2017
https://doi.org/10.1161/CIRCULATIONAHA.116.024835

Download PDF

Current Issue

Circulation: 136 (2)

Search This Journal